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Abstract.  The distribution  of the extracellular  matrix 
glycoprotein,  tenascin,  in normal  skin and healing  skin 
wounds in rats,  has been investigated by immuno- 
histochemistry.  In normal  skin,  tenascin was sparsely 
distributed,  predominantly  in association with base- 
ment membranes.  In wounds,  there  was a  marked 
increase  in the expression of tenascin at the wound 
edge in all levels of the skin.  There  was also particu- 
larly  strong tenascin  staining  at the dermal-epidermal 
junction  beneath  migrating,  proliferating  epidermis. 
Tenascin  was present throughout  the matrix  of the 
granulation  tissue,  which filled full-thickness  wounds, 
but was not detectable in the scar after wound con- 
traction  was complete.  The distribution  of tenascin 
was spatially and temporally different from that  of 
fibronectin,  and tenascin  appeared before laminin 
beneath  migrating  epidermis.  Tenascin  was not entirely 
codistributed  with myofibroblasts,  the contractile 
wound fibroblasts.  In EM  studies of wounds,  tenascin 
was localized in the basal lamina at the dermal- 
epidermal junction,  as well as in the extracellular  ma- 
trix of the adjacent dermal  stroma,  where it was either 
distributed  homogeneously or bound to the surface of 
collagen fbers.  In cultured  skin explants,  in which 
epidermis  migrated  over the cut edge of the dermis, 
tenascin,  but not fibronectin,  appeared  in the dermis 
underlying  the migrating  epithelium.  This demon- 
strates that migrating,  proliferating  epidermis  induces 
the production  of tenascin.  The results presented here 
suggest that tenascin  is important  in wound healing 
and is subject to quite different regulatory  mechanisms 
than  is fibronectin. 
W 
'OUND healing  is  a  complex  series  of biological 
events that in many ways resembles the process of 
development.  Cellular  proliferation,  migration, 
and  differentiation,  as  well  as  tissue  remodeling,  are  all 
events that occur during  embryonic and postnatal develop- 
ment and recur during wound healing. Many of the molecu- 
lar mechanisms responsible for these events are apparently 
common to development and wound healing.  Some growth 
factors that are known or thought to promote wound healing 
also have roles in development, for example, the fibroblast 
growth factors (reviewed by Thomas,  1987) and transform- 
ing  growth  factor-13 (Mustoe et al.,  1987;  Seyedin et al., 
1986). Some extracellular matrix molecules (e.g., fibronec- 
tin and collagen type III) that are abundant in embryonic skin 
and less abundant in adult skin, are reexpressed at high levels 
in healing skin wounds (Kurkinen et al., 1980; review by AI- 
varez,  1986). 
Extracellular  matrix proteins are known to be important 
in many phases of wound healing.  Fibronectin is present in 
the clot that forms at the earliest stage of healing and is abun- 
dant in the granulation  tissue that fills a deep skin wound 
(Grinnell et al., 1981). Fibronectin is thought to aid in phago- 
cytosis of wound debris and promotes migration  of wound 
fibroblasts,  endothelial  cells,  and probably epithelial  cells 
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over the wound (reviewed by Murphy-Ullrich and Mosher, 
1986). Collagen type III is increased in the early granulation 
tissue and is later replaced by collagen type I. These two col- 
lagen types impart strength to the healing wound (reviewed 
by Cohen and McCoy, 1983). Collagen and fibronectin are 
also chemotactic for fibroblasts (reviewed by Alvarez, 1986). 
Tenascin,  also known  as myotendinous antigen,  glioma 
mesenchymal  extracellular  matrix  antigen,  hexabrachion, 
brachionectin,  J1, and cytotactin, is an extracellular matrix 
glycoprotein  with  a  strikingly  limited  distribution  in  the 
mesenchymal  components  of various  organs  in  vertebrate 
embryos (Chiquet and Fambrough,  1984a;  Chiquet-Ehris- 
mann  et al.,  1986; Bourdon et al.,  1983;  Vaughan et al., 
1987; Erickson et al.,  1987; Faissner et al.,  1988; Hoffman 
et al.,  1988). Its tissue distribution suggests that tenascin is 
important in the development of mammary gland, hair folli- 
cle (Chiquet-Ehrismann  et al.,  1986, Inaguma et al.,  1988), 
muscle (Chiquet and Fambrough,  1984a), tooth (Thesleff et 
al., 1987), cartilage and bone (Mackie et al., 1987b), kidney 
(Aufderheide et al.,  1987), and neural crest and its deriva- 
tives (Mackie et al.,  1988; Epperlein et al.,  1988), as well 
as the central nervous system (Kruse et al.,  1985). Tenascin 
is absent or expressed at low levels in the adult mammary 
gland, but is abundant in mammary carcinomas (Mackie et 
al.,  1987a, Inaguma et al.,  1988). 
Little is known about the function of tenascin. Tenascin as 
a substratum supports the growth of primary mammary tu- 
mor cells in serum-free culture (Chiquet-Ehrismann  et al., 
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et al.,  1987b).  Tenascin  in  the  culture medium  partially 
inhibits  the  attachment  of wing-bud  cells  to  fibronectin 
(Mackie et al.,  1987b). In contrast, tenascin appears to act 
as a cell adhesion molecule in the central nervous system 
(Kruse et al.,  1985). 
This study was undertaken to investigate the distribution 
of tenascin in normal skin and healing skin wounds.  The 
study revealed that tenascin is sparsely distributed in normal 
rat skin, but strongly expressed in healing wounds. The in 
vivo distribution studies, as well as in vitro studies, demon- 
strate that mechanisms regulating expression of tenascin are 
quite distinct from those for fibronectin. 
Materials and Methods 
Antisera 
Tenascin was purified from the conditioned medium of primary rat embryo 
fibroblast cultures grown in DME containing 10%  FCS. The purification 
was carded out according to the method described by Chiquet and Fam- 
brough (1984b),  but instead of an mAb column, a column containing poly- 
clonal antiserum to chicken tenascin was used. Briefly, after ammonium sul- 
phate precipitation and removal of fibronectin by gelatin-agarose (Sigma 
Chemical Co., St. Louis, MO), the extract was loaded onto a column con- 
taining rabbit antiserum to chicken tenascin (Chiquet-Ehrismann et al., 
1986) coupled to cyanogen bromide-activated Sopharose-4B (Sigma Chem- 
ical Co.). The column was then washed with PBS and rat tenascin was eluted 
with 50 mM ethanolamine (pHI 1.5) and then dialyzed against PBS. Antise- 
rum to rat tenascin ("¢50  Ltg/injection)  was produced in rabbits and pro- 
cessed as described for chicken tenascin (Chiquet-Ehrismarm et al., 1986). 
The specificity of the antiserum was confirmed by Western blot analysis. 
The antiserum detected only two bands, of *240 and 200 kD, in condi- 
tinned medium of rat embryo fibroblasts. This is in agreement with the 
subunit molecular weights previously described for rat tenascin (Chiquet- 
Ehrismann et al., 1986).  The antiserum did not react with FCS or plasma 
flbronectin (Boehringer Mannheim, FRGL 
Antiserum to mouse laminin was prepared in a guinea pig using the same 
procedure as for tenascin and 100 I.tg laminin (Bethesda Research Laborato- 
ries, Gaithersburg, MD) per injection. Rabbit antiserum to human plasma 
fibronectin was purchased from Gibco Laboratories (Basel, Switzerland). 
Animals 
3-mo-old male or female outbred Sprague-Dawley rats were anesthetized. 
The abdomen was shaved or depilated with a commercial depilatory cream 
and then three scalpel incisions, one deep, one medium, and one superficial, 
were made in the abdominal skin. Deep skin wounds were full-thickness 
wounds in which all layers were cut. Medium-thickness wounds cut through 
all layers except the cutaneous muscle and varying amounts of the adipose 
tissue layer.  Superficial wounds were only cut through the epidermis and 
part of the dermis. Wounds were left uncovered and all healed without com- 
plications. Two animals were killed at each of the following time points: 
15 and 24 h and 2, 3, 6, 10, 14, and 22 d. The wounds with some surround- 
ing skin were excised and processed for histology. Four rats whose wounds 
were to be used for electron microscopy were also anesthetized 6 d after 
being  wounded and  then  subjected to  intracardiac  perfusion  with 4% 
paraformaldehyde and 0.1% glutaraldehyde in calcium- and magnesium-free 
Hanks' solution (CMF) I before the wounds were excised. 
Histology 
Tissues for immunohistochemistry at the light microscope level were fixed 
in 4% paraformaldehyde in potassium phosphate buffer (pH 7.4)  for 4 h, 
washed in PBS, and then placed in 30%  sucrose in PBS overnight. The 
wounds were then embedded in OCT compound (Tissue Tek; Miles Labora- 
tories Inc., Naperville, IL), frozen rapidly on ethanol/dry ice, and stored 
at  -70°C. Cryostat sections (10-20 ~tm) were cut and placed on gelatin- 
1.  Abbreviation  used in this paper:  CMF, calcium- and magnesium-free 
Hank's solution. 
coated slides. Sections containing adipose tissue were placed in ether for 
5 min to remove fat before staining. Sections to be stained by the immuno- 
peroxidase method were then immersed in 0.3 % hydrogen peroxide in 40 % 
methanol to remove endogenous peroxidase staining. Some sections were 
treated with bovine testicular hyaluronidase (0.1 mg/ml at 22"C for 30 min; 
Calbiochem-Behring Corp., Lucerne, Switzerland) or type I collngenase 
(0.5 mg/ml) at 37°C for 20 rain; Sigma Chemical Co.) before staining. In- 
direct immunofluorescence was carried out as described (Mackie et al., 
1988).  Some sections stained with anti-tenascin or preimmune serum, fol- 
lowed by FITC anti-rabbit Ig, were counterstained with TRITC-phalloidin 
(0.5 mg/ml in PBS for 2 min; Sigma Chemical Co.) and then washed in PBS 
before the coverslip was applied, lmmunoperoxidase staining was carded 
out according to the same procedure but with peroxidase-labeled swine 
anti-rabbit or goat anti-guinea pig Ig (Dakopatts, Glostrup, Denmark) as 
the second antibody. Chloronaphthol was used as a chromogenic substrate. 
Some sections were stained with hematoxylin and eosin by  standard 
methods. 
Electron Microscopy 
The excised wounds were fixed for 2 h in the same solution used for perfu- 
sion (described above), washed several times in CMF and cryoprotected by 
immersion in 20% sucrose in CMF for 4 h. 60-gm free-floating sections 
were cut with a freezing microtome. Suppression of endogenous peroxidase 
activity was carried out as described above.  After being rinsed several 
times, the sections were incubated with anti-tenascin or preimmune serum 
(l:100 in CMF containing 1 rng BSA/ml) for 2 h, washed (four times for 
5 min each) in CMF, and then incubated in peroxidase-labeled goat anti- 
rabbit Ig for 2 h. The sections were washed for l  h with several changes 
of buffer, and the peroxidase activity was developed with pyrocatechol/ 
p-phenylenediamine (l mg/ml in 0.15 M ammonium acetate buffer contain- 
ing 0.01% hydrogen peroxide). The stained sections were washed, posttixed 
in 1% osmium tetroxide in cacodylate buffer, and embedded in EPON. The 
sections were resectioned and examined without counterstaining in a Phil- 
lips electron microscope at 80 kV. Some wounds were fixed in 4% parafor- 
maldehyde, 2.5 % glutaraldebyde/CMF and processed for conventional EM 
histology. 
Cell and tissue Culture 
Skin explants were cultured according to the method of Hashimoto and 
Marks (1984).  Rats, as used for the wound experiments, were killed and the 
abdomens were depilated. Sheets of skin ~0.5 mm thick, were removed 
with a scalpel and cut into pieces '~3  ×  2 mm. The explants were floated, 
epidermis upward, in DME with or without FCS. The explants were cul- 
tured for 1-7 d and then fixed and processed for histology as for the wound 
tissues. 
Results 
In this study, the distribution of tenascin in skin wounds of 
various thicknesses was compared with that of fibronectin. 
The results obtained for fibronectin in normal skin and heal- 
ing wounds were  in agreement  with those previously ob- 
tained by GrinneU et al.  (1981).  The distribution of laminin 
was  used  to  indicate  the  status  of basement  membranes. 
The distribution of tenascin was also compared with that of 
actin-containing wound fibroblasts,  myofibroblasts,  which 
were  detected  using  TRITC-phalloidin,  as  previously  de- 
scribed (Doillon et al.,  1987). 
Tenascin Is Associated with Basement 
Membranes in Normal Skin 
In normal rat skin, tenascin was detected in a discontinuous 
distribution in the basement membrane of the dermal-epi- 
dermal junction, mostly close to hair follicles (Fig. 1 B). It 
was found in the basement membrane of subepidermal capil- 
laries and hair follicles, but not of sebaceous glands, which 
are associated with hair follicles. There was strong tenascin 
staining in the sheaths of  the large sensory tylotrich hair folli- 
The Journal  of Cell Biology, Volume 107, 1988  2758 Figure 1.  Distribution of tenascin in normal skin (A-D) and 24-h wounds (E-H). Hyalumnidase-treated sections stained by indirect im- 
munoperoxidase with preimmune serum (CS; A, E), anti-tenascin (Tn; B, F), and anti-fibronectin (Fn; C, G). In A-D, oblique sections 
of hair follicles (hf) are seen at two levels,  close to the surface of the skin, and deeper, where they are associated with sebaceous glands 
(sg). (B) In normal skin, tenascin is present discontinuously in the dermal-epidermal junction beneath the epidermis (e), but staining is 
strong beneath the epidermal pad (ep); it is also present in the basement membranes of dermal capillaries (c) and hair follicles, but not 
sebaceous glands.  (C) Fibronectin  is present in basement membranes and diffusely throughout the dermis.  (D) Staining  with TRITC- 
phalloidin  (Ph)  demonstrates that actin-containing  fibroblasts are rare in the fibrous dermis,  sm,  smooth muscle.  (F)  1 d  after being 
wounded, tenascin staining is increased in the dermal-epidermal junction beneath the intact epidermis to the right of the cut edge of the 
wound (arrow). Tenascin staining can also now be seen diffusely in the dermis (d) adjacent to the wound. (G) Fibronectin staining  is en- 
hanced at all levels in the region of the wound. (H) Hematoxylin and eosin (HE) staining  demonstrates the wound morphology. The dark 
band of cells to the left of the cut edge of the epithelium is an accumulation of polymorphonuclear leukocytes. Bar,  100 Ixm. 
cles and of the epidermal pads, the area of thickened epider- 
mis associated with tylotrich follicles (Straile,  1969). Other- 
wise, staining in the fibrous connective tissue of the dennis 
was undetectable,  as was staining of dermal smooth muscle. 
Tenascin staining of normal skin was considerably enhanced 
by hyaluronidase treatment of sections but unaffected by col- 
lagenase treatment. Like tenascin, fibronectin was present in 
capillary, hair follicle, and dermal-epidermal junction base- 
ment  membranes,  but  was  also  weakly  and  diffusely  dis- 
tributed  throughout  the fibrous tissue of the dermis (Fig.  1 
C).  TRITC-phalloidin  showed faint,  diffuse staining of the 
fibrous tissue of the normal dermis (Fig.  1 d), as previously 
described  (Doillon  et al.,  1987). 
Mackie e! al. Induction  of Tenascin  in Healing  Wounds  2759 Figure 2.  Distribution of extracellular matrix proteins in 3-d wounds. Fluorescence staining of adjacent hyaluronidase-treated sections of 
superficial (A-D), medium-thickness (E-G), and deep (H) wounds stained with preimmune (CS; A), anti-tenascin (Tn;  B, F, and H), 
anti-fibronectin (Fn; C, G), or anti-laminin (Ln; D) serum or with TRITC-phalloidin (Ph; E). (A-G) Arrows indicate the point where 
the epidermis was cut. (E-G) Arrowheads indicate the point to which epidermis has migrated. (A) There is background fluorescence on 
the surface of the epidermis and in the eschar. (B) In a  superficial wound, the wound edges separated slightly initially, but migrating 
epidermis (me) has already covered the wound space completely. Tenascin staining is very strong beneath the recently migrated epithelium 
The Journal of Cell Biology,  Volume 107, 1988  2760 Figure 3.  Distribution of tenascin in 6-d wounds. Fluorescence staining of a single section of granulation tissue in a deep wound with 
anti-tenascin (Tn; A) and TRITC-phalloidin (Ph; B). (A) Tenascin staining has a homogeneous extracellular distribution, whereas in the 
same field TRITC-phalloidin stains fine myofibroblast processes (B).  The arrows outline a capillary. Bar, 100 Ixm. 
Tenascin Is Strongly Expressed in Healing Wounds by 
Light Microscopy 
After surgical incision, a blood clot forms within the wound. 
Polymorphonuclear leukocytes accumulate at the edges of 
the wound.  Within  ~24  h,  epidermis at the edges of the 
wound thickens and begins to migrate between the dermis 
and the eschar, which is the remains of the clot and wound 
exudate. Over the next few days, the wound space is filled 
with  granulation  tissue,  consisting  mainly  of fibroblasts, 
macrophages, and endothelial cells forming new blood ves- 
sels. Collagen fibers are deposited and gradually organized 
parallel to the wound surface; then wound contraction takes 
place. Wound myofibroblasts are thought to be important in 
the contraction process (Majno et al., 1971; Rungger-Braen- 
die and Gabbiani, 1983). The time required for these events 
varies with the depth of the wound. 
1 d after wounding, tenascin staining had become more in- 
tense at the dermal-epidermal junction and some staining 
was apparent in the dermis adjacent to the wound edge (Fig. 
1  f). Fibronectin staining had become stronger in the dermis 
in the region surrounding the wound (Fig.  1 G). 
3 d after wounding, epidermal migration across superficial 
wounds was complete. Tenascin was abundant at the dermal- 
epidermal junction underneath the newly migrated epithe- 
lium,  and extending some distance from the wound edges 
towards the normal skin (Fig.  2 B). At this stage, laminin 
staining  was  not  yet continuous at the dermal-epidermal 
junction (Fig. 2 D). In a 3-d medium-thickness wound, there 
was  intense tenascin  staining  of the dermis at  the wound 
edge, both in the region over which epidermis had already 
migrated, and beneath the eschar where epidermis had not 
yet migrated (Fig. 2 F). Epidermis thus was migrating over 
a surface rich in tenascin. In both superficial and medium- 
thickness wounds, the distinction between the wound area 
and  adjacent normal tissue  was  much more obvious with 
tenascin staining  (Fig.  2,  B  and F)  than with fibronectin 
staining (Fig. 2, C and G). In a deeper 3-d wound in which 
the muscle layer was  partially damaged,  a  sharp band of 
intense tenascin staining was visible all along the edge of 
the  wound,  in  dermis,  adipose  tissue,  and  muscle  layers 
(Fig. 2 H). 
Because tenascin is known to be produced by fibroblasts 
in culture and by various mesenchymal tissues (see Introduc- 
tion) it seemed likely that the specialized wound fibroblasts, 
myofibroblasts, produce tenascin.  Double  staining  of sec- 
tions with anti-tenascin and TRITC-phalloidin demonstrated 
that tenascin's distribution was not well correlated with that 
of myofibroblasts (Fig. 2, E and F). The area of dermis that 
was adjacent to the wound edge and contained myofibroblasts 
was more extensive than that containing tenascin. 
In deep 6-d rat wounds, the wound space had been filled 
by a large amount of granulation tissue which had been par- 
tially covered by migrating epidermis.  There was  intense 
tenascin staining in the granulation tissue (Fig. 3 A). Newly 
formed blood vessels in the granulation tissue could be seen 
by phalloidin staining of endothelium (Fig.  3 B).  Tenascin 
was not present in the basement membranes of these new 
vessels, which is demonstrated by comparison of tenascin 
and phalloidin staining of a single section at a high magnifi- 
cation (Fig. 3, A and B). This section also demonstrates that, 
although bundles of actin in myofibroblast processes could 
easily be observed (Fig.  3  B),  very few tenascin-stained 
and in the injured dermis, c, capillary; d, dermis; e, epithelium; es, eschar; hf, hair follicle. (C) Fibronectin staining is enhanced in the 
wound area, but is also present in the noninjured dermis. (D) Laminin staining beneath the newly migrated epidermis is not yet continuous. 
In a section of a medium-thickness wound, double-stained with TRITC-phalloidin (E) and anti-tenascin (F), the area of actin-containing 
myofibroblasts in the dermis is more widespread than the area of tenascin staining. (F) Tenascin is present in the dermis at the wound 
edge. Staining of the dermal-epidermal junction becomes weaker with increasing distance from the wound. (G) Fibronectin staining does 
not show the sharp distinction between wounded and nonwounded dermis that is seen with anti-tenascin (F). (H) Intense tenascin staining 
lines the edge of a deep wound in adipose tissue (at) and skeletal muscle (sk) layers. Arrowheads show the line between intact tissue and 
eschar. Bar, 100 btm. 
Mackie et al. Induction of Tenascin in Healing Wounds  2761 Figure 4. Distribution of tenascin in hyaluronidase-treated sections of wounds after contraction. (A and B) Fluorescence staining of adjacent 
sections of a 10-d medium-thickness wound with anti-tenascin  (Tn; A) and anti-fibronectin  (Fn; B). Tenascin is now almost absent deep 
in the scar (s), but remains at high levels high in the scar beneath the epidermis  (e). hf, hair follicle. (B) Fibronectin  is still abundant 
throughout the scar. (C and D) A deep 22-d wound stained with anti-tenascin  (C) or preimmune (D) serum.  (C) By 22 d, tenascin is 
found in capillary basement membranes within the scar, but is absent from the fibrous component of the scar. Bar, 100 ~tm. 
fibrils were visible (Fig.  3 A). Tenascin thus was predomi- 
nantly distributed homogeneously throughout the extracellu- 
lar spaces of the granulation tissue at this stage. 
With  time,  granulation  tissue  contracts,  bringing  the 
former wound edges back together. The abundant granula- 
tion tissue is replaced by a  narrow  scar of collagen fibers 
aligned parallel to the surface of the wound. Soon after con- 
traction had taken place, in a  medium-thickness wound at 
10 d, tenascin was only just detectable deep in the scar, but 
still abundant high in the scar close to the dermal-epidermal 
junction (Fig. 4 A). In contrast, fibronectin was still evenly 
distributed in the scar (Fig. 4 B).  Tenascin was not present 
in the basement membrane of blood vessels in the scar soon 
after contraction (Fig. 4 A), but had reappeared in the capil- 
laries close to the epidermis some time later, when tenascin 
was totally undetectable in the fibrous tissue of the scar (Fig. 
4  C). 
Ultrastructure of the Dermal-Epidermal Junction in 
Normal and Wounded Skin 
To understand  in  more detail  the  architecture  of the  der- 
mal-epidermal junction, wound tissue with the adjacent un- 
wounded skin was investigated by EM.  Attention was paid 
to the reestablishment of the basal lamina between epidermis 
and dermis (Fig.  5).  In normal skin,  a  70-nm-thick basal 
lamina separated the epidermis from the dermis. The epider- 
mal cells adhered to the basal lamina by numerous hemides- 
mosomes. The dermal stroma was invested with a dense net- 
work of 55-nm-thick collagen fibers (Fig.  5  B).  From the 
margin to the center of the wound, the basal lamina became 
thinner (40 nm) and progressively more discontinuous (Fig. 
5, C-E). The basal lamina fragments were always apposed 
to the epidermal hemidesmosomes (see Fig. 5 D). In the cen- 
ter  of the  wound,  a  basal  lamina was  not  detectable  and 
pioneer epidermal cells were sitting on an amorphous mass 
of extracellular matrix (Fig.  5 F),  or were in contact with 
macrophages (Fig.  5  G).  At the margin of the granulation 
tissue,  the dermal  stroma contained  a  network of 30-nm- 
thick collagen fibers (Fig. 5, C-E), whereas in the center of 
the wound amorphous matrix material was abundant (Fig. 5, 
E  and F). 
Ultrastructural Detection of Tenascin in Normal and 
Wound 1Issue 
In normal skin, tenascin was detected in the basal lamina of 
the dermal capillaries (Fig. 6 A) as well as in the basal lamina 
of the hair follicles (Fig. 7 B). The collagen fibers that were 
apposed to  these basal  laminae were also  decorated  with 
tenascin. Collagen fibers >2 ~tm away from the basal lamina 
were tenascin  negative (Figs.  6  A  and 7  B).  The identity 
of the collagen fibers was established by counterstaining of 
the sections with uranyl acetate and lead citrate (Fig. 6 B). 
In the wound tissue, the distribution of tenascin changed 
from the margin to the center of the wound. At the periphery, 
where epidermis was intact but thickened, tenascin antibod- 
ies stained both the basal lamina (predominantly apposing 
the hemidesmosomes) and the surface of the collagen fibers 
in  the  adjacent  dermal  stroma (Fig.  7,  C  and D).  At the 
Figure 5. (A) Semithin plastic section showing one half of a deep 6-d wound. At the left margin, normal epidermal cells (E) are resting 
on dermis (D), which consists of fibroblasts and collagen fibers. At the edge of the wound, there is an indentation of epidermis into dermis, 
as is often seen. At this point (d) there is a sharp division between normal dermis and granulation tissue (G). Note the different organization 
of normal dermis (few cells and many thick collagen fibers) and the granulation tissue (many cells and few or no collagen fibers). The 
border between epidermis and granulation tissue is indicated by arrowheads. F, fat. In B-G, EM photomicrographs show in more detail 
the various regions of the dermal-epidermal junction  shown in (A). In normal skin (B), a thick basal lamina (BL), hemidesmosomes, 
and thick collagen fibers (arrowheads) are found. (C) At the margin of  the wound the basal lamina is discontinuous and thinner. The collagen 
The Journal of Cell Biology, Volume 107, 1988  2762 fibers are also thinner  (arrowheads: compare with collagen fibers in B). (D and E) The basal lamina fragments (arrowheads) are discontinu- 
ous and are found directly apposed to the epidermal hemidesmosomes  (squares).  (F) No basal lamina is present and amorphous extracellu- 
lar matrix material (ECM-G) is present in the granulation tissue.  (g) A pioneer epithelial cell contacts a macrophage  (M). Bars: (A) 100 
lam; (B-G) 0.25 ~tm. 
Mackie et al. Induction of Tenascin in Healing Wounds  2763 Figure 6. (A) Electron micrograph showing tenascin staining along the basal lamina (BL, arrowheads) of a dermal blood vessel in normal 
skin. Collagen fibers adjacent to the basal lamina are also stained; however, collagen fibers further away (stars) are negative. The collagen 
fibers were identified by the lead citrate and uranyl acetate staining of the same section (B). The luminal border of the endothelial cell 
(E) is indicated by a broken line. Bar, 0.25 ~tm. 
former wound edge, where the earliest epidermal migration 
had occurred, tenascin was found in the basal lamina frag- 
ments that separated the epidermal from the dermal cells 
(Fig. 7 E).  Staining of thick collagen fibers was no longer 
detectable and the tenascin in the stroma adjacent to the der- 
mal-epidermal junction decorated an amorphous mass of  ex- 
traceUular matrix. In the central areas of  the wound, tenascin 
was only detectable in the amorphous matrix of the granula- 
tion tissue (Fig.  7 F). 
Migrating Epidermis Induces the Production 
of Tenascin by the Dermis 
To determine whether any of the multitude of cytokines pro- 
duced by the invading cells attracted to the site of injury were 
necessary for the production of tenascin by the dermis, skin 
explants were studied. It has previously been demonstrated 
that when skin explants are cultured floating on the surface 
of the medium, epidermis migrates over the cut edge of the 
dermis (Hashimoto et al.,  1984). Epidermal cell migration 
even occurs, albeit more slowly,  in serum-free medium. 
When such skin explants were cultured and then sectioned 
and examined by histochemistry, it was found that tenascin 
staining was strong in the dermal-epidermal junction and ad- 
jacent dermis under migrating epithelium (Fig.  8 B).  Epi- 
dermis from explants cultured in serum-free medium did not 
migrate as  far,  but tenascin was  expressed under the epi- 
dermis that had migrated (not shown).  Staining with anti- 
fibronectin (Fig. 7 C) and TRITC-phalloidin (Fig. 7 D) was 
weak and evenly spread throughout the sections, as in nor- 
mal skin. 
Discussion 
Tenascin in normal skin was found to be only associated with 
basement membranes and hair follicle dermal sheaths. It was 
weakly and discontinuously detected at the dermal-epider- 
mal junction. Tenascin was, however, strongly expressed in 
healing wounds.  This dramatic change in  expression sug- 
gests that tenascin is important in the wound healing process. 
The association of tenascin with basement membranes, 
demonstrated in this study, is intriguing. Tenascin was de- 
tected in the basement membranes of subepidermal capil- 
laries in normal skin, but not in capillaries of granulation tis- 
sue  or  the  newly  contracted scar.  Tenascin was  sparsely 
distributed in the basement membrane of normal epidermis, 
but abundant in the immature basement membrane of wound 
epidermis. In one situation tenascin thus indicates a mature 
basement membrane, and in another, an immature basement 
membrane. 
Staining for tenascin was very intense at the dermal-epi- 
dermal junction beneath recently migrated epidermis and be- 
neath the thickened, proliferating epidermis at the edges of 
the  wound,  extending  towards  the  normal  skin.  In  vitro, 
tenascin was again expressed at the dermal-epidermal junc- 
The Journal of Cell Biology, Volume  107, 1988  2764 Figure 7. Immunohistochemical detection  of tenascin  in a wound and in adjacent  skin.  An overview of the tenascin  distribution  of a deep 
6-d wound is shown in A. The center of the wound is on the left and unwounded  skin is on the right.  Tenascin staining  was found in the 
basal lamina (BL) of hair follicles  (b), of the dermal-epidermal junction at the wound edge (C and E) and in the granulation tissue  (G). 
E, epidermis.  The staining  of the eschar and of the surface of the epidermis is not specific.  In B-F, electron micrographs show the der- 
mal_epidermal junction at high magnification.  (B) In the hair follicle, tenascin is found in the basal lamina and on the surface of  the collagen 
fibers in the adjacent dermal stroma. (C) At the wound edge, tenascin is found in the basal lamina between dermis and epidermis, predomi- 
nantly apposed to the hemidesmosomes (H), and on the collagen fibers of the adjacent  stroma.  (D) Collagen fibers of the dermal stroma, 
decorated by anti-tenascin, are shown in cross section.  (E) Further into the wound,  anti-tenascin stains the discontinuous basal  lamina 
fragments at the dermal-epidermal junction. In the stroma, tenascin  stains the amorphous matrix of the granulation tissue.  (F) Under re- 
cently migrated  epidermis towards the center of the wound, tenascin  is only found in matrix of the granulation tissue.  No basal  lamina 
is detectable.  (G) No staining  is seen  in sections  incubated  with  preimmune serum.  Bars:  (A)  100/.tm;  (B-G) 0.25 /am. 
tion and in the dermis immediately underlying migrating epi- 
thelium.  Such tenascin staining was not seen at the cut edge 
of the dermis, where epithelium had not yet migrated; it thus 
can be concluded that migrating, proliferating epithelium in- 
duces the expression of tenascin by dermal cells. This induc- 
tion does not require  the presence  of serum or of the cell 
types,  absent  from  normal  skin,  that  appear  in  healing 
wounds. 
Tenascin expressed at the dermal-epidermal junction may 
play a role in epidermal cell migration.  Not only was tenas- 
cin found to be expressed  in response to migrating epider- 
mis, but it was also strongly expressed in the wound surface 
Mackie et al. Induction  of Tenascin  in Healing  Wounds  2765 Figure 8. Induction of tenascin by migrating epithelium. Skin explants were cultured for 2 d in the presence of FCS, and then sectioned 
and stained by indirect immunoperoxidase with preimmune (CS; A), anti-tenascin (Tn; B) or anti-fibronectin (Fn; C) serum, or with 
TRITC-phalloidin (Ph; D).  All the epidermis (e) visible in these micrographs has migrated over the cut edge of the dermis (d) during 
the culture period. The arrowhead denotes the front of migrating epidermis. (B) Strong tenascin staining is seen at the dermal-epidermal 
junction and in the adjacent dermis. Fibronectin (C) and actin-containing fibroblasts stained with TRITC-phalloidin (D) are distributed 
as in normal skin. Bar, 100 Ism. 
encountered by the front of migrating epidermis. The ability 
to migrate is an intrinsic property of epidermal cells, and can 
be markedly enhanced by epidermal growth factor and trans- 
forming  growth  factor-~t  (Barrandon  and  Green,  1987); 
tenascin  thus  is  obviously not  required  for migration.  It 
seems likely, however, that a tenascin-containing substratum 
could provide ideal conditions for optimal movement of an 
epidermal cell sheet across the surface of a wound. The dis- 
tribution of tenascin is well correlated with the pathways of 
neural crest cell migration and it has been speculated that 
tenascin promotes the migration of neural crest ceils by pre- 
venting them from attaching too well to fibronectin (Mackie 
et al.,  1988). A similar mechanism could also be involved 
in epidermal cell migration. On the other hand, the finding 
that tenascin is localized in basement membrane fragments 
opposite hemidesmosomes suggests that tenascin may be in- 
volved in adhesion of migrating epidermis. 
Tenascin was  strongly expressed at wound edges in the 
dermis and in the granulation tissue that filled deep wounds. 
In these areas, the distribution of tenascin was not well cor- 
related with that of  myofibroblasts. The electron microscopic 
study demonstrates that, in the dermis, tenascin associates 
either directly or indirectly with native collagen fibers. The 
coating of collagen fibers with tenascin may alter the interac- 
tion of cells or other extracellular matrix components with 
collagen. In the young granulation tissue at the center of the 
wound, in which no collagen fibers were seen, tenascin was 
present in amorphous deposits. Perhaps tenascin is only ever 
present in a fibrillar distribution when it can associate with 
collagen fibers. 
The presence of  tenascin in granulation tissue suggests that 
it may play a role in the development of this transient tissue. 
Fibronectin and collagen are known to promote fibroblast 
migration (Knox et al.,  1986; Postlethwaite et al.,  1978).  It 
is  possible that  tenascin,  yet another extracellular matrix 
component, promotes migration into the wound area.  The 
role of tenascin is, however, probably quite different from 
that  of fibronectin, as  their patterns  of expression are  so 
different. For example, tenascin may influence wound con- 
traction.  The  contractile properties  of myofibroblasts are 
widely  thought  to  be  responsible  for  wound  contraction 
(reviewed by Rungger-Braendle and Gabbiani, 1983). It has 
been  suggested,  however,  that  because myofibroblasts re- 
main in the scar for some time after contraction, it is unlikely 
that these cells alone account for wound contraction (Doillon 
et al.,  1987). In this study, it was observed that granulation 
tissue ,x,5 mm across contracted to a  scar ~50  ~tm wide. 
Whether or not myofibroblasts contract during wound con- 
traction,  they must also  move considerably in  relation to 
other ceils and the extracellular matrix surrounding them for 
this 100-fold reduction in wound width to be able to occur. 
Indeed, Baur and Parks  (1983)  have proposed a  model of 
wound contraction in which myofibroblasts use their con- 
tractile ability to migrate through the extracellular matrix. 
These authors have described the myofibroblast anchoring 
strand, a direct connection between actin bundles within the 
myofibroblast and collagen fibers without. This connection 
would allow the translation of migratory movement into tis- 
sue deformation or wound contraction. Tenascin, which in- 
hibits the attachment of mesenchymal cells to fibronectin in 
vitro (Mackie et al.,  1987b), could limit the myofibroblast's 
ability to adhere to the extracellular matrix surrounding it, 
thus allowing it to continue moving. Indeed, tenascin disap- 
peared  more  rapidly  than  fibronectin or  actin-containing 
myofibroblasts after wound contraction was complete. After 
contraction, unimpeded adherence of cells to the surround- 
ing matrix through fibronectin would once more be desir- 
able, to stabilize the scar. 
The results of this study suggest that tenascin has an im- 
portant and unique role in the wound healing process and 
demonstrate that its expression is subject to regulatory mech- 
anisms quite different from those for fibronectin. 
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